Dyne reports 12-month data for DM1 drug z-basivarsen

🌐 Investing.com (Cyprus) —
Dyne reports 12-month data for DM1 drug z-basivarsen

AI Summary

Dyne reported 12-month data for z-basivarsen, its investigational drug for myotonic dystrophy type 1. The headline does not provide the specific outcomes or indicate any regulatory decision.

Markets Health Dyne Therapeutics z-basivarsen myotonic dystrophy type 1 clinical data drug development

Read original source →